Insights into the Worldwide HRT Industry to 2027 - Featuring Abbott Laboratories, Novartis & Pfizer Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hormone Replacement Therapy Market Size, Share & Trends Analysis Report by Product (Estrogen, Human Growth), by Route Of Administration (Oral, Parenteral), by Type Of Disease, by Region, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.

The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027, expanding at a CAGR of 7.7%. A significant rise in the incidence rate of hormonal disorders in the newborns, adults, and elderly and populations is driving the market. The Prader-Willi syndrome (PWS) affects one in every 15,000 newborns, thereby boosting the demand for the therapy.

Estrogen replacement hormone therapy helps in reducing the vaginal indications of menopause, such as dryness, burning, itching, and pain during intercourse. Estrogen is available in the forms of pill, gel, skin patch, cream or spray form. It is highly successful for treating problematic menopausal night sweats and hot flashes. Around 45% of women between the ages of 40 to 60 years of age were reported taking counseling sessions from a physician regarding the advantages and disadvantages of using hormone replacement therapy (HRT) after menopause.

Growing awareness about menopausal signs and the treatment options is growing the HRT market. Owing to the significant development for ERT, there has been an initiation of very safe treatment options for the patients situated in various geographies of the world. For example, augmentation of innovative drug delivery systems like transdermal estrogen patches and vaginal estrogen drugs.

Further key findings from the report suggest:

• The estrogen replacement therapy segment dominated the overall market in terms of revenue share in the year 2019. On the other hand, the parenteral segment is likely to showcase the fastest growth rate over the forecast period from 2020 to 2027, owing to the rising number of hormonal disorders
• Menopause is likely to showcase the fastest growth rate over the forecast period. Women are vulnerable to certain diseases and conditions such as osteoporosis and hot flashes during and after menopause. About 73% of postmenopausal women suffer from hot flashes
• North America dominated the overall hormone replacement therapy market in terms of revenue share in the year 2019. The increase in the incidence rate of hypogonadism due to a rise in obesity and poor health in the geriatric population drive the market. According to the American Academy of Family Physicians, more than 2.5 million Americans received testosterone treatment in U.S alone in 2014

Key Topics Covered:

1. Methodology and Scope

2. Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

2.2.1 Product

2.2.2 Route of Administration

2.2.3 Type of Disease

2.2.4 Region

2.3 Competitive Insights

3. Market Variables, Trends & Scope

3.1 Market Segmentation

3.2 Penetration & Growth Prospect Mapping

3.2.1 Market Driver Analysis

3.2.2 Market Restraint Analysis

3.3 Hormone Replacement Therapy Market: Business Environment Analysis Tools

3.3.1 Porter's Five Forces Analysis

3.3.2 PESTEL Analysis

4. Hormone Replacement Therapy Market: Product Analysis

4.1 Hormone Replacement Therapy Product Market Share Analysis, 2019 & 2027

4.2 Hormone Replacement Therapy Product Market: Segment Dashboard

4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Product Segment

4.3.1 Estrogen Hormone Replacement Therapy

4.3.2 HGH Replacement Therapy

4.3.3 Thyroid Hormone Replacement Therapy

4.3.4 Testosterone Hormone Replacement Therapy

5. Hormone Replacement Therapy Market: Route of Administration Analysis

5.1 Hormone Replacement Therapy Route of Administration Market Share Analysis, 2019 & 2027

5.2 Hormone Replacement Therapy Route of Administration Market: Segment Dashboard

5.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Route of Administration Segment

5.3.1 Oral

5.3.2 Parenteral

5.3.3 Transdermal

5.3.4 Others

6. Hormone Replacement Therapy Market: Type of Disease Analysis

6.1 Hormone Replacement Therapy Type of Disease Market Share Analysis, 2019 & 2027

6.2 Hormone Replacement Therapy Type of Disease Market: Segment Dashboard

6.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Type of Disease Segment

6.3.1 Menopause

6.3.2 Hypothyroidism

6.3.3 Male Hypogonadism

6.3.4 Growth Hormone Deficiency

6.3.5 Others

7. Hormone Replacement Therapy Market: Regional Analysis

7.1 Hormone Replacement Therapy Regional Market Share Analysis, 2019 & 2027

7.2 Hormone Replacement Therapy Regional Market: Segment Dashboard

7.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)

7.4 Market Size, & Forecasts, and Trend Analysis, 2016 to 2027

7.4.1 North America

7.4.2 Europe

7.4.3 Asia Pacific

7.4.4 Latin America

7.4.5 Middle East and Africa (MEA)

8. Competitive Analysis

8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players

8.2 Vendor Landscape

8.3 Company market position analysis (Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)

8.4 Company Profiles

Companies Mentioned

• Abbott Laboratories
• Novartis
• Pfizer
• Mylan Laboratories
• Merck & Co.
• Amgen
• Novo Nordisk
• Bayer
• Eli Lilly
• Genentech

For more information about this report visit https://www.researchandmarkets.com/r/rowxnu